Schaaf-Yang症候群に対するアンチセンス核酸治療法の確立

• Project/Area Number: 21K15908
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 52050:Embryonic medicine and pediatrics-related
• Research Institution: Nagoya City University
• Principal Investigator: 家田 大輔 名古屋市立大学, 医学(系)研究科(研究院), その他 (70745950)
• Project Period (FY): 2021-04-01 – 2023-03-31
• Project Status: Adopted (Fiscal Year 2021)
• Budget Amount: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000); Fiscal Year 2022: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000); Fiscal Year 2021: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)